Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow Quality Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Quality Index of 3.76x as of September 2025. Operating cash flow of CN¥486.04 Million exceeds net income of CN¥129.10 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Shyndec Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Quality Index (2004–2025)
Historical Cash Flow Quality Index for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600420 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year earnings quality comparison for Shanghai Shyndec Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market value of Shanghai Shyndec Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.80x | CN¥1.70 Billion | CN¥944.38 Million | ▲ +6.2% |
| 2024 | 1.69x | CN¥2.26 Billion | CN¥1.33 Billion | ▼ -5.0% |
| 2023 | 1.78x | CN¥1.72 Billion | CN¥964.61 Million | ▼ -60.8% |
| 2022 | 4.55x | CN¥2.86 Billion | CN¥627.79 Million | ▲ +53.9% |
| 2021 | 2.96x | CN¥1.68 Billion | CN¥568.28 Million | ▲ +70.5% |
| 2020 | 1.73x | CN¥1.56 Billion | CN¥900.05 Million | ▲ +26.7% |
| 2019 | 1.37x | CN¥1.27 Billion | CN¥928.47 Million | ▼ -12.3% |
| 2018 | 1.56x | CN¥1.67 Billion | CN¥1.07 Billion | ▼ -44.8% |
| 2017 | 2.83x | CN¥2.31 Billion | CN¥818.57 Million | ▲ +188.0% |
| 2016 | 0.98x | CN¥838.58 Million | CN¥854.03 Million | ▲ +26.3% |
| 2015 | 0.78x | CN¥226.65 Million | CN¥291.55 Million | ▼ -25.6% |
| 2014 | 1.04x | CN¥258.51 Million | CN¥247.54 Million | ▼ -5.6% |
| 2013 | 1.11x | CN¥207.50 Million | CN¥187.51 Million | ▼ -13.2% |
| 2012 | 1.28x | CN¥193.41 Million | CN¥151.67 Million | ▲ +37.6% |
| 2011 | 0.93x | CN¥136.12 Million | CN¥146.92 Million | ▲ +7.2% |
| 2010 | 0.86x | CN¥115.11 Million | CN¥133.12 Million | ▼ -3.5% |
| 2009 | 0.90x | CN¥97.43 Million | CN¥108.70 Million | ▲ +12.1% |
| 2008 | 0.80x | CN¥58.04 Million | CN¥72.58 Million | ▲ +9.9% |
| 2007 | 0.73x | CN¥82.31 Million | CN¥113.11 Million | ▼ -34.5% |
| 2006 | 1.11x | CN¥73.60 Million | CN¥66.29 Million | ▲ +35.3% |
| 2005 | 0.82x | CN¥57.90 Million | CN¥70.53 Million | ▲ +134.7% |
| 2004 | 0.35x | CN¥17.02 Million | CN¥48.66 Million | — |